Clutters are unwanted components of the received signal. In contrast enhanced ultrasound, clutter often describes the part of the received echo that is not from microbubble contrast agents.

See also Release Burst Imaging.

(CCI) A major limitation of the use of ultrasound contrast agents is the problem that signals from the microbubbles are mixed with those from tissue, so that the distribution of the microbubbles is not optimally displayed either in Doppler or gray scale.
Coherent contrast imaging is a high frame rate implementation of inverting the phase of alternate sound pulses and summing the resulting echoes. The symmetrical signals from linear reflectors are cancelled leaving those from non-linear scatterers, with the advantage that the cancellation is performed without the need to transmit two pulses per image line so that bubble destruction is minimized. Coherent contrast imaging yields best results in the vascular phase of phospholipid microbubbles (such as Definity and SonoVue).

See also Coherence.

(CAI) Color amplitude imaging shows the amplitude of the Doppler signal from moving blood flow. CAI is an ultrasound technique with increased dynamic range and flow sensitivity. The sensitivity of Doppler ultrasound increases markedly in conjunction with the use of vascular contrast agents.

See also Amplitude Map, Amplitude Indicator.

(CDI) Color Doppler imaging depicts the mean frequency shifts of the Doppler signal. Color [colour, Brit.] Doppler imaging is a method for visualizing direction and velocity of movement, such as of blood flow within the cardiac chambers or blood vessels. The flow direction and velocity information gathered by Doppler ultrasonography is color coded onto a gray scale cross-sectional image. The sensitivity of Doppler ultrasound is increased in conjunction with the use of vascular contrast agents.
Direction and blood flow velocity are coded as colors and shades:
Red - flow coming nearer to the probe.
Blue - flow coming away of the probe.

See also Bi-directional Illumination, Color Map.

From Lantheus Medical Imaging.
Activated DEFINITY® Injectable Suspension is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border. The perflutren lipid microspheres exhibit lower acoustic impedance than blood and enhance the intrinsic backscatter of blood.
Echocardiography with Definity produced more detailed images of the heart in difficult-to-image patients versus echocardiography alone, and images obtained with the contrast agent provided a more accurate assessment of segmental wall motion compared with unenhanced images.

See also Coherent Contrast Imaging.

In August 2001 DuPont Pharmaceuticals Company received FDA approval.